Immunoglobulin Restores Immune Responses to BTH1677 in Patients With Low Levels of Antibodies to Beta-glucan.

Background: BTH1677 is a beta-glucan pathogen-associated molecular pattern (PAMP) being evaluated as a novel immunotherapy of cancer. We previously described that the presence of antibodies against beta-glucan (ABA) in serum is necessary for BTH1677 antitumoral activity. We hypothesized that infusion of immunoglobulin can reinstate responses to BTH1677 in individuals with low ABA levels.

An approach for estimating exposure to ambient concentrations.

The degree of certainty in epidemiological studies is probably limited more by estimates of exposure than by any other component. We present a methodology for computing daily pollutant concentration fields that reduces exposure uncertainty and bias by taking account of spatial variation in air quality. This approach, using elliptical influence functions, involves the optimum blending of observations from a monitoring network with gridded pollution fields predicted by the complex air quality model TAPM.